Rare Neuroendocrine Breast Cancer Not So Unusual Rare Neuroendocrine Breast Cancer Not So Unusual
Neuroendocrine breast cancer can be indistinguishable from high-grade ductal carcinoma, although treatment is different, and can be missed unless stained specifically for neuroendocrine markers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 7, 2017 Category: Consumer Health News Tags: Pathology & Lab Medicine News Source Type: news
Local DCIS Recurrence After Skipping Adjuvant Radiation Local DCIS Recurrence After Skipping Adjuvant Radiation
Omitting radiation after lumpectomy for pure ductal carcinoma in situ (DCIS) does not improve the chance of breast preservation in case of local recurrence, researchers from Canada have observed.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 6, 2017 Category: Surgery Tags: Hematology-Oncology News Source Type: news
COUNTERPOINT: Should Radiation Therapy After Surgery for Ductal Carcinoma In Situ Be Standard Practice?
To universally recommend breast irradiation for all women after excision of DCIS lesions ignores information now available to us that can spare the majority of women with DCIS the downsides of RT, but be applied in the treatment of DCIS patients at greater risk for invasive disease. (Source: CancerNetwork)
Source: CancerNetwork - August 15, 2017 Category: Cancer & Oncology Authors: William C. Wood, MD Tags: Breast Cancer Oncology Journal Source Type: news
POINT: Should Radiation Therapy After Surgery for Ductal Carcinoma In Situ Be Standard Practice?
At this time RT following BCS remains the standard of care for most patients. Current tools, including prognostic scores and tumor genetics, have failed to identify a cohort for whom RT confers no benefit with respect to invasive recurrences. (Source: CancerNetwork)
Source: CancerNetwork - August 15, 2017 Category: Cancer & Oncology Authors: Camille Berriochoa, MD Carisa Bohnak, BS Chirag Shah, MD Nicole Chahine, BS Tags: Breast Cancer Oncology Journal Source Type: news
Benefit of Radiotherapy After Breast Conservation in DCIS Benefit of Radiotherapy After Breast Conservation in DCIS
Can this molecular assay help determine who will benefit from radiotherapy after breast-conserving therapy for DCIS?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 27, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Don ’t Be Fooled by DCIS
A 46-year-old woman had a routine screening mammogram that showed new calcifications in the posterior left breast. A diagnostic mammogram showed several small punctate calcifications, and a 6-month interval follow-up was recommended. (Source: CancerNetwork)
Source: CancerNetwork - July 15, 2017 Category: Cancer & Oncology Authors: Colleen D. Murphy, MD Dulcy E. Wolverton, MD Rachel A. Rabinovitch, MD Regina J. Brown, MD Sharon Sams, MD, MPH Tae Chong, MD Virginia F. Borges, MD, MMSc Tags: Breast Cancer Case Studies Oncology Journal Source Type: news
Case: Traumatic Neuroma of the Breast After Mastectomy Case: Traumatic Neuroma of the Breast After Mastectomy
What was the etiology of this small mass found on screening mammogram in a woman with a history of invasive ductal carcinoma and modified radical mastectomy?Applied Radiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 3, 2017 Category: Consumer Health News Tags: Radiology Journal Article Source Type: news
Photoacoustic imaging could guide breast cancer removal
A new technique based on photoacoustic imaging could help surgeons determine...Read more on AuntMinnie.comRelated Reading:
Contrast US helps assess breast cancer treatment response
Bilateral mastectomy not needed for DCIS
DBT reduces breast surgery re-excision rates
Supine MRI in the OR can improve breast surgery outcome
Lumpectomy with RT tops mastectomy for early-stage cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 17, 2017 Category: Radiology Source Type: news
' Unique' DCIS Study: Double Mastectomy Not Needed'Unique' DCIS Study: Double Mastectomy Not Needed
Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 2, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Triple-modality therapy foils rare breast cancer
Traditional triple-modality therapy for breast cancer also works for a rare...Read more on AuntMinnie.comRelated Reading:
ASTRO: Radiation boost cuts local recurrence in DCIS patients
Choosing Wisely boosts use of short-course breast radiation therapy
Accelerated RT with boost works well for breast cancer patients
Bras aid positioning for large-breasted women during RT
ASCO BSC: Long-term APBI outcomes are favorable (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 28, 2017 Category: Radiology Source Type: news
Bilateral mastectomy not needed for DCIS
Women with ductal carcinoma in situ (DCIS) who choose bilateral mastectomy...Read more on AuntMinnie.comRelated Reading:
How accurate are DCIS predictions from radiologists?
Overdiagnosis claims not supported, ACR, SBI say
ASTRO: Radiation boost cuts local recurrence in DCIS patients
New treatment guidelines issued for DCIS
Needle biopsy hormone testing unnecessary for DCIS (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 28, 2017 Category: Radiology Source Type: news
Bilateral Mastectomy in DCIS May Be Overtreatment
Women who undergo bilateral mastectomy for the treatment of DCIS may be overtreated, according to the results of a new study. (Source: CancerNetwork)
Source: CancerNetwork - April 27, 2017 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Breast Cancer News Source Type: news
How accurate are DCIS predictions from radiologists?
Radiologists can predict the presence of invasive cancer with fairly high accuracy,...Read more on AuntMinnie.comRelated Reading:
Mammography recall rates: Is lower really always better?
Cochrane group again takes aim at breast screening
Does screening DBT increase short-term follow-up rates?
Risk-based mammo screening misses almost 60% of cancersComments:
3/30/2017 4:18:32 AMDr.Sardonicus
Amazing that these people got a paper in AJR saying, essentially, that radiologists are unable to read detailed histology from mammograms with perfect accuracy. Did anyone ever think differently? There is a reason...
Source: AuntMinnie.com Headlines - March 30, 2017 Category: Radiology Source Type: news
ASTRO partners with ASCO's CancerLinQ
The American Society for Radiation Oncology (ASTRO) announced that it plans...Read more on AuntMinnie.comRelated Reading:
ASTRO updates guidelines on painful bone metastases
Elekta to support ASTRO safety initiative
ASTRO releases updated APBI guide
ASTRO: Radiation boost cuts local recurrence in DCIS patients
ASCO debuts database of 100K patient records (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 22, 2017 Category: Radiology Source Type: news
Mayo Clinic tests vaccine to provide immune response against early breast lesion
(Mayo Clinic) Only about 35 percent of precancerous breast lesions morph into cancer if untreated, but physicians cannot identify which lesions are potentially dangerous. So all women diagnosed with ductal carcinoma in situ undergo traditional therapy of surgery and possibly hormonal therapy and radiation. Now, Mayo Clinic researchers are about to test a vaccine that they hope will replace standard therapies and prevent recurrence for some, if not all, these patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 1, 2017 Category: Global & Universal Source Type: news
Mayo Clinic to test vaccine designed to provide immune response against early breast lesions
JACKSONVILLE, Fla. ? Only about 35 percent of precancerous breast lesions morph into cancer if untreated, but physicians cannot identify which lesions are potentially dangerous. So all women diagnosed with ductal carcinoma in situ undergo traditional therapy of surgery and possibly hormonal therapy and radiation. Now, Mayo Clinic researchers are about to test a vaccine [...] (Source: Mayo Clinic Florida News)
Source: Mayo Clinic Florida News - January 31, 2017 Category: Hospital Management Source Type: news
New Research Shows Breast Cancer Precursor Treatment Causes Women to Live Longer
This study is particularly important because DCIS treatment includes radiotherapy, which can cause damage to nearby organs
More and more people are becoming aware they have DCIS because it is something that shows up in breast cancer screenings—so more women are able to get treated if they have this form of cancer.
For more information on the study, please visit “Women treated for precursor of breast cancer can expect to live as long as other women.”
Follow NN/LM SCR on Twitter and like us on Facebook. (Source: Network News)
Source: Network News - January 31, 2017 Category: Databases & Libraries Authors: NN/LM South Central Region Tags: Consumer Health General (all entries) Patient Safety Public Health Research Source Type: news
Women with DCIS Breast Ca Don't See Greater Death Risk
(MedPage Today) -- And other reports from the European Cancer Congress (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - January 31, 2017 Category: Journals (General) Source Type: news
Women With DCIS Live Longer Than General Population Women With DCIS Live Longer Than General Population
The clinical trial was halted after two patients died, but the deaths were related to the use of fludarabine in the preconditioning regimen.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 30, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Medical News Today: Women with noninvasive breast cancer live as long as other women
Women diagnosed with ductal carcinoma in situ have a slightly higher risk of dying from breast cancer, but a significantly lower all-mortality risk. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 30, 2017 Category: Consumer Health News Tags: Breast Cancer Source Type: news
Women treated for early signs of breast cancer live LONGER
Women over the age of 50 with ductal carcinoma in situ - a precursor of breast cancer - were 10 per cent more likely to be alive ten years after their diagnosis than health women, Dutch researchers found. (Source: the Mail online | Health)
Source: the Mail online | Health - January 28, 2017 Category: Consumer Health News Source Type: news
Good News for Older Women With Early Form of Breast Cancer
A diagnosis of DCIS doesn't lower life expectancy in patients over 50, study finds (Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - January 28, 2017 Category: Cancer & Oncology Source Type: news
Good news for older women with early form of breast cancer
A new study offers some reassuring statistics about DCIS, a very early form of breast cancer (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - January 27, 2017 Category: Consumer Health News Source Type: news
Good News for Older Women With Early Breast Cancer
A diagnosis of DCIS doesn't lower life expectancy in patients over 50, study finds (Source: WebMD Health)
Source: WebMD Health - January 27, 2017 Category: Consumer Health News Source Type: news
Good News for Older Women with Early Form of Breast Cancer
A diagnosis of DCIS doesn't lower life expectancy in patients over 50, study finds
Source: HealthDay
Related MedlinePlus Page: Breast Cancer (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - January 27, 2017 Category: Consumer Health News Source Type: news
Women treated for precursor of breast cancer can expect to live as long as other women
Women over 50 who have been treated for ductal carcinoma in situ (DCIS), a precursor of breast cancer, are more likely to be alive ten years later than women in the general population, according to new research. Researchers say these results should provide reassurance to women who are diagnosed with the disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 27, 2017 Category: Science Source Type: news
Good News for Older Women With Early Form of Breast Cancer
FRIDAY, Jan. 27, 2017 -- Older women treated for a very early form of breast cancer, called ductal carcinoma in situ (DCIS), do not have an overall increased risk of early death compared to their peers, a new study finds. " Being diagnosed with DCIS... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 27, 2017 Category: Journals (General) Source Type: news
Women treated for precursor of breast cancer can expect to live as long as other women
(ECCO-the European CanCer Organisation) Women over 50 who have been treated for ductal carcinoma in situ (DCIS), a precursor of breast cancer, are more likely to be alive ten years later than women in the general population, according to new research presented at the European Cancer Congress 2017. Researchers say these results should provide reassurance to women who are diagnosed with the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 27, 2017 Category: Cancer & Oncology Source Type: news
Good News for Older Women With Early Form of Breast Cancer
A diagnosis of DCIS doesn't lower life expectancy in patients over 50, study finds (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 26, 2017 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Family Medicine, Gynecology, Nursing, Oncology, News, Source Type: news
Cochrane group again takes aim at breast screening
Continuing a campaign going back to at least 2000, researchers from the Nordic...Read more on AuntMinnie.comRelated Reading:
Kopans: New NEJM paper offers rehash on 'overdiagnosis'
NEJM: Treatment, not screening, cuts breast cancer deaths
5 ways imaging can reduce breast cancer overdiagnosis
Mammography in Nordic countries: Screening and new developments
Kopans: JAMA Oncology paper misinterprets DCIS data (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 10, 2017 Category: Radiology Source Type: news
Study: Mammography Results in Overdiagnosis, No Reduction in Advanced Disease
Breast cancer screening was not associated with any reduction in the incidence of advanced cancer, and overdiagnosis of invasive tumors and ductal carcinoma in situ is a common problem, according to a new study conducted in Denmark. (Source: CancerNetwork)
Source: CancerNetwork - January 9, 2017 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer News Screening Source Type: news
Reoperation Rates 3-Fold Higher After DCIS Than IBC Reoperation Rates 3-Fold Higher After DCIS Than IBC
Patients undergoing breast-conserving surgery had reoperation rates 3 times higher when when their diagnosis was ductal carcinoma in situ (DCIS) than when it was invasive breast cancer (IBC).Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 9, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Breast cancer screening associated with substantial overdiagnosis
(American College of Physicians) Breast cancer screening in Denmark was associated with a substantial increase in the incidence of nonadvanced tumors and DCIS but not with a reduction in the incidence of advanced tumors. The rate of overdiagnosis was also substantial. The findings of a cohort study are published in Annals of Internal Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 9, 2017 Category: Cancer & Oncology Source Type: news
Our Most Read Cancer Stories of 2016
This slide show highlights some of the most read stories on Cancer Network in 2016, including guidelines on surgical margins in DCIS, a study on serum vitamin D levels in breast cancer patients, and more. (Source: CancerNetwork)
Source: CancerNetwork - December 20, 2016 Category: Cancer & Oncology Authors: Cancer Network Editors Source Type: news
New ASTRO Guidelines for APBI in Early-Stage Breast Cancer New ASTRO Guidelines for APBI in Early-Stage Breast Cancer
The new guideline extends the candidates for accelerated partial-breast irradiation (APBI) to younger women and those with ductal carcinoma in situ.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 23, 2016 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Guideline Boosts Patient Pool Eligible for APBI
(MedPage Today) -- Younger patients, those with DCIS included in ASTRO update (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - November 18, 2016 Category: Hematology Source Type: news
ASTRO releases updated APBI guide
The American Society for Radiation Oncology (ASTRO) has released an updated...Read more on AuntMinnie.comRelated Reading:
ASTRO: PET predicts outcomes in vulvar cancer patients
ASTRO: Radiation boost cuts local recurrence in DCIS patients
ASTRO: Negative PET/CT doesn't always mean dormant NSCLC
ASTRO: Prostate cancer has 3 molecular subtypes
ASTRO: OK to cut RT dose for primary medulloblastoma (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 17, 2016 Category: Radiology Source Type: news
Top Breast Cancer News of 2016
This slide show highlights some of the top breast cancer news of 2016, including a study looking at optimal margins in DCIS, a trial on biosimilars, a new FDA approval, and more. (Source: CancerNetwork)
Source: CancerNetwork - November 16, 2016 Category: Cancer & Oncology Authors: Cancer Network Editors Tags: Breast Cancer Year in Review 2016 Source Type: news
Older DCIS Patients Have Low Rates of Tamoxifen, AI Usage
The initiation of and adherence to tamoxifen or aromatase inhibitors (AIs) such as anastrozole is low among older women with estrogen receptor-positive ductal carcinoma in situ. (Source: CancerNetwork)
Source: CancerNetwork - November 1, 2016 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer News Source Type: news
Shortened RT works for low-risk prostate cancer patients
A shortened, higher-dose radiation therapy (RT) protocol is safe for low-risk...Read more on AuntMinnie.comRelated Reading:
ASTRO: PET predicts outcomes in vulvar cancer patients
ASTRO: Radiation boost cuts local recurrence in DCIS patients
ASTRO: Negative PET/CT doesn't always mean dormant NSCLC
ASTRO: Prostate cancer has 3 molecular subtypes
ASTRO: OK to cut RT dose for primary medulloblastoma (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 4, 2016 Category: Radiology Source Type: news
Benefit of Radiation Boost in DCIS Validated (CME/CE)
(MedPage Today) -- Small but significant increase in recurrence-free survival (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 30, 2016 Category: Hematology Source Type: news
Should DCIS Patients Get a Radiation Boost? Should DCIS Patients Get a Radiation Boost?
Pooled analysis of 4000 patients with ductal carcinoma in situ shows that a radiation boost reduces local recurrence.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 29, 2016 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
ASCO releases updated breast RT guideline
The American Society of Clinical Oncology (ASCO) has released an updated guideline...Read more on AuntMinnie.comRelated Reading:
New treatment guidelines issued for DCIS
ASCO BCS: Breast MRI useful for average-risk women, too
ASCO BCS research highlights benefits of mobile mammo, PET/MR
ASTRO publishes guidelines for accelerated whole-breast RT
IMRT reduces skin toxicity symptoms for breast cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 29, 2016 Category: Radiology Source Type: news
ASTRO: Radiation boost cuts local recurrence in DCIS patients
A supplemental boost of radiation cuts breast cancer recurrence in women with...Read more on AuntMinnie.comRelated Reading:
New treatment guidelines issued for DCIS
Needle biopsy hormone testing unnecessary for DCIS
Delayed rad therapy puts women with DCIS at risk
ASBrS: No, we're not overtreating DCIS
New study to examine how to treat early breast cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 28, 2016 Category: Radiology Source Type: news
ASTRO: Outreach boosts radiation therapy rates for blacks
BOSTON - A patient outreach program essentially eliminated the treatment gap...Read more on AuntMinnie.comRelated Reading:
ASNR 2016: Race and sex affect who gets brain imaging
Delayed rad therapy puts women with DCIS at risk
Socioeconomic factors affect patient care in radiology
Racial discrepancies persist in breast cancer diagnoses (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 26, 2016 Category: Radiology Source Type: news
Young Age and DCIS Tied to Increased Risk of Breast Tumor Recurrence Young Age and DCIS Tied to Increased Risk of Breast Tumor Recurrence
In women ages 40 and younger, the presence of ductal carcinoma in situ (DCIS) next to an invasive tumor is associated with an increased risk of ipsilateral breast tumor recurrence (IBTR), according to a recently published study.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 16, 2016 Category: Surgery Tags: Hematology-Oncology News Source Type: news
DCIS Score Fails Cost-Effectiveness Test DCIS Score Fails Cost-Effectiveness Test
The Oncotype DX DCIS Score was not cost-effective in any of five different treatment strategies that were analyzed.Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 15, 2016 Category: Surgery Tags: Hematology-Oncology News Source Type: news
Current Trends in the Management of Ductal Carcinoma In Situ
This review will summarize the current trends in the diagnosis and management of DCIS and will highlight ongoing trials that are shaping future management of this entity. (Source: CancerNetwork)
Source: CancerNetwork - September 15, 2016 Category: Cancer & Oncology Authors: E. Shelley Hwang, MD, MPH Tristen S. Park, MD Tags: Breast Cancer Oncology Journal Review Article Source Type: news
Common breast cancer test may not be worth the cost, UCLA study suggests
A genomic test widely used to help determine whether women with a common form of breast cancer should undergo radiation is not cost effective, according to a new UCLA Jonsson Comprehensive Cancer Center study. The Oncotype DX DCIS test is given to women with ductal carcinoma in situ, which means the cancer has not spread to any other tissues, to help them choose the best treatment by better identifying the potential of tumors to come back.Oncotype DX DCIS reduces the number of women undergoing radiation therapy, which is good because it decreases the number of women exposed to possibly harmful side effects. However, UCLA J...
Source: UCLA Newsroom: Health Sciences - September 13, 2016 Category: Universities & Medical Training Source Type: news
Presence of DCIS, Younger Age Affect Breast Cancer Recurrence Risk
The presence of DCIS adjacent to invasive breast tumor and a younger age at diagnosis are associated with increased risk of ipsilateral breast tumor recurrence. (Source: CancerNetwork)
Source: CancerNetwork - September 9, 2016 Category: Cancer & Oncology Authors: Anna Azvolinsky Tags: Breast Cancer News Source Type: news
